SANA
Price
$4.09
Change
+$0.05 (+1.24%)
Updated
Dec 4, 6:59 PM EST
100 days until earnings call
VERV
Price
$12.01
Change
+$0.22 (+1.87%)
Updated
Dec 4, 6:59 PM EST
98 days until earnings call
Ad is loading...

SANA vs VERV ᐉ Comparison: Which is Better to Invest?

Header iconSANA vs VERV Comparison
Open Charts SANA vs VERVBanner chart's image
Sana Biotechnology
Price$4.09
Change+$0.05 (+1.24%)
Volume$839.07K
CapitalizationN/A
Verve Therapeutics
Price$12.01
Change+$0.22 (+1.87%)
Volume$758.46K
CapitalizationN/A
View a ticker or compare two or three
SANA vs VERV Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
SANA vs. VERV commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SANA is a Hold and VERV is a Hold.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (SANA: $4.08 vs. VERV: $11.98)
Brand notoriety: SANA and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SANA: 101% vs. VERV: 70%
Market capitalization -- SANA: $835.84M vs. VERV: $736.98M
SANA [@Biotechnology] is valued at $835.84M. VERV’s [@Biotechnology] market capitalization is $736.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SANA’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • SANA’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SANA’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • SANA’s TA Score: 4 bullish, 5 bearish.
  • VERV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SANA is a better buy in the short-term than VERV.

Price Growth

SANA (@Biotechnology) experienced а -3.77% price change this week, while VERV (@Biotechnology) price change was +3.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.58%. For the same industry, the average monthly price growth was +26.31%, and the average quarterly price growth was +25.79%.

Reported Earning Dates

SANA is expected to report earnings on Mar 14, 2024.

VERV is expected to report earnings on Mar 11, 2024.

Industries' Descriptions

@Biotechnology (+5.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SANA($836M) has a higher market cap than VERV($737M). SANA YTD gains are higher at: 3.544 vs. VERV (-37.933). VERV has higher annual earnings (EBITDA): -212.02M vs. SANA (-266.82M). VERV has more cash in the bank: 485M vs. SANA (269M). VERV has less debt than SANA: VERV (76.8M) vs SANA (96.9M). VERV has higher revenues than SANA: VERV (7.63M) vs SANA (0).
SANAVERVSANA / VERV
Capitalization836M737M113%
EBITDA-266.82M-212.02M126%
Gain YTD3.544-37.933-9%
P/E RatioN/A3.16-
Revenue07.63M-
Total Cash269M485M55%
Total Debt96.9M76.8M126%
TECHNICAL ANALYSIS
Technical Analysis
SANAVERV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTANX11.23N/A
N/A
Fidelity Asset Manager® 30%
CFGRX43.56N/A
N/A
Commerce Growth
FASCX10.49N/A
N/A
K2 Alternative Strategies C
JMVPX34.54N/A
N/A
JPMorgan Mid Cap Value R3
NGJCX17.41N/A
N/A
Nuveen Global Real Estate Securities C

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+1.87%
BEAM - VERV
62%
Loosely correlated
-0.03%
CRSP - VERV
61%
Loosely correlated
+4.17%
NTLA - VERV
55%
Loosely correlated
+0.16%
MDGL - VERV
52%
Loosely correlated
+4.16%
PGEN - VERV
50%
Loosely correlated
+2.52%
More